These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15655554)

  • 1. Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer.
    Thuret R; Chantrel-Groussard K; Azzouzi AR; Villette JM; Guimard S; Teillac P; Berthon P; Houlgatte A; Latil A; Cussenot O
    Br J Cancer; 2005 Jan; 92(2):236-40. PubMed ID: 15655554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
    Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
    BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer.
    Mearini E; Antognelli C; Del Buono C; Cochetti G; Giannantoni A; Nardelli E; Talesa VN
    Biomarkers; 2009 Jun; 14(4):235-43. PubMed ID: 19489685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer.
    Hillenbrand M; Bastian M; Steiner M; Zingler C; Müller M; Wolff JM; Seiter H; Schuff-Werner P
    Anticancer Res; 2000; 20(6D):4995-6. PubMed ID: 11326656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved sensitivity and specificity for prostate cancer diagnosis based on the urine PCA3/PSA ratio acquired by sequence‑specific RNA capture.
    Zheng K; Dou Y; He L; Li H; Zhang Z; Chen Y; Ye A; Liu W; Kong L
    Oncol Rep; 2015 Nov; 34(5):2439-44. PubMed ID: 26351770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three-gene panel on urine increases PSA specificity in the detection of prostate cancer.
    Rigau M; Ortega I; Mir MC; Ballesteros C; Garcia M; Llauradó M; Colás E; Pedrola N; Montes M; Sequeiros T; Ertekin T; Majem B; Planas J; Ruiz A; Abal M; Sánchez A; Morote J; Reventós J; Doll A
    Prostate; 2011 Dec; 71(16):1736-45. PubMed ID: 21520154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate.
    Gelmini S; Tricarico C; Petrone L; Forti G; Amorosi A; Dedola GL; Serio M; Pazzagli M; Orlando C
    Clin Chem Lab Med; 2003 Mar; 41(3):261-5. PubMed ID: 12705330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
    Castaldo G; Cecere G; di Fusco V; Prezioso D; d'Armiento M; Salvatore F
    Clin Chim Acta; 1997 Sep; 265(1):65-76. PubMed ID: 9352130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of urine DD3/PSA mRNA ratio by duplex TaqMan RT-PCR assay and evolution of its primary application].
    Chen FP; Chen LL; Shen M; Chen W; Tao ZH; Wu XL; Hu YP; Li CD; Chen ZG; Chen XD
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):261-4. PubMed ID: 18361839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.
    Hessels D; Klein Gunnewiek JM; van Oort I; Karthaus HF; van Leenders GJ; van Balken B; Kiemeney LA; Witjes JA; Schalken JA
    Eur Urol; 2003 Jul; 44(1):8-15; discussion 15-6. PubMed ID: 12814669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of PSA-RNA yield on the analysis of expressed prostatic secretions (EPS) for prostate cancer diagnosis.
    Whelan C; Crocitto L; Kawachi M; Chan K; Smith D; Wilson T; Smith S
    Can J Urol; 2013 Feb; 20(1):6597-602. PubMed ID: 23433128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy.
    Valeri A; Fromont G; Sakr W; Azzouzi R; Dey J; Chantrel-Groussard K; Latil A; Berthon P; Cussenot O; Pontes JE; Cher ML
    Urol Oncol; 2005; 23(2):87-92. PubMed ID: 15869992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood.
    Henke W; Jung M; Jung K; Lein M; Schlechte H; Berndt C; Rudolph B; Schnorr D; Loening SA
    Int J Cancer; 1997 Jan; 70(1):52-6. PubMed ID: 8985090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.
    Zielie PJ; Mobley JA; Ebb RG; Jiang Z; Blute RD; Ho SM
    J Urol; 2004 Sep; 172(3):1130-3. PubMed ID: 15311056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary prostate specific antigen: is the clinical use likely?
    Pejcic T; Hadzi-Djokic J; Acimovic M; Topuzovic C; Milkovic B; Janjic A
    Acta Chir Iugosl; 2005; 52(4):69-74. PubMed ID: 16673599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of recurrent PSA after radical prostatectomy: benign versus malignant sources.
    Ravery V
    Semin Urol Oncol; 1999 Aug; 17(3):127-9. PubMed ID: 10462314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR.
    Moreno JG; O'Hara SM; Long JP; Veltri RW; Ning X; Alexander AA; Gomella LG
    Urology; 1997 Apr; 49(4):515-20. PubMed ID: 9111619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and prognostic value of quantitative monitoring of prostate specific antigen in blood serum and urine from patients with prostate cancer after radical prostatectomy].
    Mazo EB; Grigor'ev ME; Stepenskiĭ AB; Lebedev DV
    Ter Arkh; 2002; 74(10):65-7. PubMed ID: 12469637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies in using urine samples for Prostate Cancer detection: PSA and PCA3 expression analysis.
    Fontenete S; Silva J; Teixeira AL; Ribeiro R; Bastos E; Pina F; Medeiros R
    Int Braz J Urol; 2011; 37(6):719-26. PubMed ID: 22234006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
    Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
    Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.